XML 107 R35.htm IDEA: XBRL DOCUMENT v3.24.2
GOODWILL AND INTANGIBLE ASSETS (Tables)
 6 Months Ended
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
A reconciliation of changes in the Company’s goodwill by reportable segment were as follows:

(in millions)Connected Technology SolutionsEssential Dental SolutionsOrthodontic and Implant SolutionsWellspect HealthcareTotal
Balance at December 31, 2023
Goodwill$291 $840 $1,323 $275 $2,729 
Accumulated impairment losses (a)
(291)— — — (291)
Goodwill, net at December 31, 2023— 840 1,323 275 2,438 
Impairment— — — — — 
Foreign Currency Translation
— (8)(36)(5)(49)
Balance at June 30, 2024
Goodwill$291 $832 $1,287 $270 $2,389 
Accumulated impairment losses (a)
$(291)$— $— $— $— 
Goodwill, net at June 30, 2024$— $832 $1,287 $270 $2,389 
(a) The Company realigned segments in 2023, and at that time, there was an accumulated impairment loss that was not allocated to the new segments.
Schedule of Definite-lived and Indefinite-lived Intangible Assets
Identifiable definite-lived and indefinite-lived intangible assets were as follows:

June 30, 2024December 31, 2023
(in millions)Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
Developed technology and patents$1,659 $(1,043)$616 $1,697 $(1,006)$691 
Trade names and trademarks
270 (107)163 271 (102)169 
Licensing agreements30 (28)2 30 (27)3 
Customer relationships1,044 (698)346 1,070 (680)390 
Total definite-lived3,003 (1,876)1,127 3,068 (1,815)1,253 
Indefinite-lived trade names and trademarks
427 — 427 447 — 447 
In-process R&D (a)
5 — 5 5 — 5 
Total indefinite-lived432 — 432 452 — 452 
Total identifiable intangible assets$3,435 $(1,876)$1,559 $3,520 $(1,815)$1,705 
(a) Intangible assets acquired in a business combination that are in-process and used in research and development ("R&D") activities are considered indefinite-lived until the completion or abandonment of the R&D efforts. The useful life and amortization of those assets will be determined once the R&D efforts are completed.